Volume: 34 Issue: 23

1. Common problems and counterplans of extracorporeal membrane oxygenation implementation in neonatal intensive care unit Page:1761—1766
2. Developmental status and prospect of artificial placenta Page:1766—1769
3. Advance on stem cells therapy for bronchopulmonary dysplasia Page:1770—1773
4. Investigation on epidemiology of nosocomial sepsis of premature infants with gestational age less than 34 weeks in Shaanxi province: a multicenter study Page:1774—1777
5. Risk factors for the failure of the INSURE strategy in premature infants with respiratory distress syndrome Page:1778—1782
6. The relationship between the continuous opening of arterial catheters and platelet parameters in preterm infants Page:1783—1787
7. Analysis of clinical manifestations, cranial imaging changes and prognosis of 76 cases with neonatal cerebral infarction Page:1788—1791
8. Effect of delayed cord clamping on cerebral tissue oxygen saturation in newborns Page:1792—1795
9. Association between corticotropin releasing hormone receptor 1 (rs4458044) polymorphism and persistent pulmonary hypertension of the newborn Page:1796—1798
10. Changes in ventricular late potentials in children and adolescents with postural tachycardia syndrome Page:1799—1802
11. Comparison of N-terminal pro-brain natriuretic peptide and echocardiography in the early diagnosis of Kawasaki disease Page:1803—1806
12. Clinical analysis of relapsed demyelinating disease associated with myelin oligodendrocyte glycoprotein antibody in children Page:1807—1811
13. Clinical features of the children with malignancy-associated hemophagocytic syndrome in Beijing Page:1812—1815
14. Comparative analysis of different surgical methods for treating esophageal atresia Page:1816—1819
15. Progress on PM2.5 and its adverse impact on lung tissues Page:1828—1830
16. Advances on erythropoietin treatment of anemia in prematurity infants Page:1831—1833
17. Minimally invasive application of alveolar surfactant in neonatal respiratory distress syndrome Page:1834—1837
18. Progress on treating of glomerular diseases with adrenocorticotrophic hormone Page:1837—1840
19. Common problems and counterplans of extracorporeal membrane oxygenation implementation in neonatal intensive care unit Page:1761—1766
20. Developmental status and prospect of artificial placenta Page:1766—1769
21. Advance on stem cells therapy for bronchopulmonary dysplasia Page:1770—1773
22. Investigation on epidemiology of nosocomial sepsis of premature infants with gestational age less than 34 weeks in Shaanxi province:a multicenter study Page:1774—1777
23. Risk factors for the failure of the INSURE strategy in premature infants with respiratory distress syndrome Page:1778—1782
24. The relationship between the continuous opening of arterial catheters and platelet parameters in preterm infants Page:1783—1787
25. Analysis of clinical manifestations, cranial imaging changes and prognosis of 76 cases with neonatal cerebral infarction Page:1788—1791
26. Effect of delayed cord clamping on cerebral tissue oxygen saturation in newborns Page:1792—1795
27. Association between corticotropin releasing hormone receptor 1 (rs4458044)polymorphism and persistent pulmonary hypertension of the newborn Page:1796—1798
28. Changes in ventricular late potentials in children and adolescents with postural tachycardia syndrome Page:1799—1802
29. Comparison of N-terminal pro-brain natriuretic peptide and echocardiography in the early diagnosis of Kawasaki disease Page:1803—1806
30. Clinical analysis of relapsed demyelinating disease associated with myelin oligodendrocyte glycoprotein antibody in children Page:1807—1811
31. Clinical features of the children with malignancy-associated hemophagocytic syndrome in Beijing Page:1812—1815
32. Comparative analysis of different surgical methods for treating esophageal atresia Page:1816—1819
33. Diagnostic value of mean platelet volume and platelet/lymphocyte ratio in testicular torsion and epididymitis in children Page:1820—1822
34. Case report of primary meningeal melanocytoma in children Page:1823—1825
35. Identification of a family with hereditary spherocytosis caused by a novel mutation of ANK1 gene Page:1826—1827
36. Progress on PM2.5 and its adverse impact on lung tissues Page:1828—1830
37. Advances on erythropoietin treatment of anemia in prematurity infants Page:1831—1833
38. Minimally invasive application of alveolar surfactant in neonatal respiratory distress syndrome Page:1834—1837
39. Progress on treating of glomerular diseases with adrenocorticotrophic hormone Page:1837—1840